Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xilio Therapeutics, Inc. | 31,000 | reported | 11 Jun 2025 | tx 4+82,400 |
| CG Oncology, Inc. | 20,889 | reported | 24 Nov 2025 | tx 1+20,889 |
| Blueprint Medicines Corp | 0 | reported | 17 Jul 2025 | tx 59+400,618−398,368 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Nov 2025 | GRANT_AWARD | CG Oncology, Inc. | 20,889 | 0.00 USD | deriv |
| 17 Jul 2025 | TENDER | Blueprint Medicines Corp | 20,628 | — | |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 82,374 | — | |
| 17 Jul 2025 | GRANT_AWARD | Blueprint Medicines Corp | 39,456 | — | |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 30,000 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 30,000 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 30,000 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 26,400 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 80,000 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 6,500 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 28,500 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 26,125 | — | deriv |
| 03 Jul 2025 | SALE | Blueprint Medicines Corp | 1,172 | 128.25 USD | |
| 11 Jun 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 31,000 | 0.00 USD | deriv |
| 19 May 2025 | SALE | Blueprint Medicines Corp | 804 | 100.14 USD | |
| 19 May 2025 | SALE | Blueprint Medicines Corp | 57 | 101.72 USD | |
| 19 May 2025 | SALE | Blueprint Medicines Corp | 1,413 | 100.67 USD | |
| 05 May 2025 | SALE | Blueprint Medicines Corp | 1,343 | 101.77 USD | |
| 05 May 2025 | SALE | Blueprint Medicines Corp | 144 | 103.56 USD | |
| 05 May 2025 | SALE | Blueprint Medicines Corp | 180 | 102.82 USD | |
| 05 May 2025 | SALE | Blueprint Medicines Corp | 607 | 100.97 USD | |
| 24 Mar 2025 | SALE | Blueprint Medicines Corp | 2,274 | 95.02 USD | |
| 05 Mar 2025 | SALE | Blueprint Medicines Corp | 6,495 | 88.80 USD | |
| 01 Mar 2025 | GRANT_AWARD | Blueprint Medicines Corp | 13,200 | 0.00 USD | |
| 01 Mar 2025 | GRANT_AWARD | Blueprint Medicines Corp | 26,400 | 0.00 USD | deriv |